Categories Earnings, Retail

American Eagle Outfitters (AEO): Q3 2019 Earnings Snapshot

— American Eagle Outfitters Inc. (NYSE: AEO) reported its third-quarter 2019 earnings of $0.48 per share versus $0.48 per share expected.

— Total net revenue grew by 6% to $1.07 billion versus $1.06 billion expected.

American Eagle Outfitters (AEO) Q3 2019 Earnings Snapshot

— Consolidated comparable sales increased 5%, following an 8% comparable sales increase last year, and was positive across both store and digital channels.

— By brand, American Eagle’s comparable sales rose 2% and Aerie’s comparable sales increased 20%.

— Gross margin fell to 38.2% from 39.8% last year. The decline primarily reflected increased markdowns.

— During the quarter, the company opened 6 American Eagle stores, ending with 945 American Eagle stores, including 170 Aerie side-by-side locations.

— The company opened 12 Aerie stand-alone stores and closed 1, ending with 142 Aerie stand-alone stores. Internationally, the company ended the quarter with 241 licensed stores compared to 223 last year.

— For the fourth quarter, the management expects EPS of $0.34 to $0.36, with comparable sales about flat. This is lower than the analysts’ expectations of $0.48 per share. Last year, the company posted an EPS of $0.43.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top